T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer
- PMID: 35648709
- DOI: 10.1056/NEJMe2204283
T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer
Comment on
-
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.N Engl J Med. 2022 Jun 2;386(22):2112-2119. doi: 10.1056/NEJMoa2119662. N Engl J Med. 2022. PMID: 35648703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous